| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 2,076,671 | 1,834,300 | 1,470,517 | 1,455,632 | | Cost of Revenue | 1,762,122 | 1,558,063 | 1,240,210 | 1,256,396 | | | Gross Profit | 314,549 | 276,237 | 230,307 | 199,236 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 218,122 | 206,225 | 184,062 | 230,164 | | Non Recurring | (50,494) |
-
|
-
| 2,678 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 146,921 | 70,012 | 46,245 | (33,606) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21,826 | (21,453) | 15,719 | 735 | | Earnings Before Interest And Taxes | 168,747 | 48,559 | 61,964 | (32,871) | | Interest Expense | 1,348 | 1,066 | 1,026 | 1,525 | | Income Before Tax | 167,399 | 47,493 | 60,938 | (34,396) | | Income Tax Expense | 64,428 | 18,745 | 23,415 | (12,522) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 102,971 | 28,748 | 37,523 | (21,874) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 102,971 | 28,748 | 37,523 | (21,874) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $102,971 | $28,748 | $37,523 | ($21,874) |
|
0.02% Nasdaq 0.00%
Income Statement
